Pharma Edition
Communications Leaders Risk Survey
Digital chatter has accelerated the risk landscape for pharma brands. Our latest survey reveals which risks pharma communications leaders are most concerned about, and how the risk signals embedded within digital chatter can protect their brands from reputational damage.
By clicking the button below, you agree that Resolver will use your information to contact you about relevant products, content and events. You can unsubscribe from these communications at any time. For more information, see our Privacy Policy
What we heard
Resolver surveyed more than 100 in-house communications leaders to reveal the risk areas where pharma professionals outpace or lag their cross‑industry peers in readiness for a crisis. Of the pharma communications professionals surveyed:
82% say they are taking on more responsiblity for identifying risks.
76% say they expect to face three or more crises this year.
64% expect to face a crisis ignited by misinformation.
Key findings
- Pharma communicators expect to encounter more crises than their peers
- Societal risks are top of mind for nearly all pharma communicators
- Pharma communicators are preparing for a rise in misinformation
- Digital chatter has shortened response times for pharma communications teams
- New risk intelligence solutions are critical for building resilience in pharma